These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 38154590)

  • 1. Varenicline but not cotinine increased the value of a visual stimulus reinforcer in rats: No evidence for synergy of the two compounds.
    Houser SD; McNealy KR; Barrett ST; Bevins RA
    Pharmacol Biochem Behav; 2024 Feb; 235():173702. PubMed ID: 38154590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A behavioral economic analysis of the value-enhancing effects of nicotine and varenicline and the role of nicotinic acetylcholine receptors in male and female rats.
    Barrett ST; Geary TN; Steiner AN; Bevins RA
    Behav Pharmacol; 2018 Sep; 29(6):493-502. PubMed ID: 29634495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The high-affinity nAChR partial agonists varenicline and sazetidine-A exhibit reinforcing properties in rats.
    Paterson NE; Min W; Hackett A; Lowe D; Hanania T; Caldarone B; Ghavami A
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Dec; 34(8):1455-64. PubMed ID: 20708056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Varenicline serves as the training stimulus in the drug-discriminated goal-tracking task with rats: initial evaluation of potential neuropharmacological processes.
    Thompson BM; Tracy ME; Huynh YW; Dwoskin LP; Barrett ST; Bevins RA
    Behav Pharmacol; 2023 Feb; 34(1):12-19. PubMed ID: 36730812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Varenicline attenuates nicotine-enhanced brain-stimulation reward by activation of alpha4beta2 nicotinic receptors in rats.
    Spiller K; Xi ZX; Li X; Ashby CR; Callahan PM; Tehim A; Gardner EL
    Neuropharmacology; 2009 Jul; 57(1):60-6. PubMed ID: 19393252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differentiating the primary reinforcing and reinforcement-enhancing effects of varenicline.
    Schassburger RL; Levin ME; Weaver MT; Palmatier MI; Caggiula AR; Donny EC; Sved AF
    Psychopharmacology (Berl); 2015 Mar; 232(5):975-83. PubMed ID: 25209677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological profile of the alpha4beta2 nicotinic acetylcholine receptor partial agonist varenicline, an effective smoking cessation aid.
    Rollema H; Chambers LK; Coe JW; Glowa J; Hurst RS; Lebel LA; Lu Y; Mansbach RS; Mather RJ; Rovetti CC; Sands SB; Schaeffer E; Schulz DW; Tingley FD; Williams KE
    Neuropharmacology; 2007 Mar; 52(3):985-94. PubMed ID: 17157884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic sazetidine-A maintains anxiolytic effects and slower weight gain following chronic nicotine without maintaining increased density of nicotinic receptors in rodent brain.
    Hussmann GP; DeDominicis KE; Turner JR; Yasuda RP; Klehm J; Forcelli PA; Xiao Y; Richardson JR; Sahibzada N; Wolfe BB; Lindstrom J; Blendy JA; Kellar KJ
    J Neurochem; 2014 May; 129(4):721-31. PubMed ID: 24422997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Self-Administration of Cotinine in Wistar Rats: Comparisons to Nicotine.
    Ding ZM; Gao Y; Sentir AM; Tan X
    J Pharmacol Exp Ther; 2021 Mar; 376(3):338-347. PubMed ID: 33361363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacologic characterization of a nicotine-discriminative stimulus in rhesus monkeys.
    Cunningham CS; Javors MA; McMahon LR
    J Pharmacol Exp Ther; 2012 Jun; 341(3):840-9. PubMed ID: 22438471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of nicotine, varenicline, and cytisine on schedule-controlled responding in mice: differences in α4β2 nicotinic receptor activation.
    Cunningham CS; McMahon LR
    Eur J Pharmacol; 2011 Mar; 654(1):47-52. PubMed ID: 21172344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New insights on the effects of varenicline on nicotine reward, withdrawal and hyperalgesia in mice.
    Bagdas D; Alkhlaif Y; Jackson A; Carroll FI; Ditre JW; Damaj MI
    Neuropharmacology; 2018 Aug; 138():72-79. PubMed ID: 29860196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Divergent functional effects of sazetidine-a and varenicline during nicotine withdrawal.
    Turner JR; Wilkinson DS; Poole RL; Gould TJ; Carlson GC; Blendy JA
    Neuropsychopharmacology; 2013 Sep; 38(10):2035-47. PubMed ID: 23624742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Varenicline is a potent partial agonist at α6β2* nicotinic acetylcholine receptors in rat and monkey striatum.
    Bordia T; Hrachova M; Chin M; McIntosh JM; Quik M
    J Pharmacol Exp Ther; 2012 Aug; 342(2):327-34. PubMed ID: 22550286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, selectively decreases ethanol consumption and seeking.
    Steensland P; Simms JA; Holgate J; Richards JK; Bartlett SE
    Proc Natl Acad Sci U S A; 2007 Jul; 104(30):12518-23. PubMed ID: 17626178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parallel anxiolytic-like effects and upregulation of neuronal nicotinic acetylcholine receptors following chronic nicotine and varenicline.
    Turner JR; Castellano LM; Blendy JA
    Nicotine Tob Res; 2011 Jan; 13(1):41-6. PubMed ID: 21097981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Varenicline blocks β2*-nAChR-mediated response and activates β4*-nAChR-mediated responses in mice in vivo.
    Ortiz NC; O'Neill HC; Marks MJ; Grady SR
    Nicotine Tob Res; 2012 Jun; 14(6):711-9. PubMed ID: 22241831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of varenicline on the reinforcing and discriminative stimulus effects of cocaine in rhesus monkeys.
    Gould RW; Czoty PW; Nader SH; Nader MA
    J Pharmacol Exp Ther; 2011 Nov; 339(2):678-86. PubMed ID: 21856860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of chronic varenicline treatment on nicotine, cocaine, and concurrent nicotine+cocaine self-administration.
    Mello NK; Fivel PA; Kohut SJ; Carroll FI
    Neuropsychopharmacology; 2014 Apr; 39(5):1222-31. PubMed ID: 24304823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic sazetidine-A at behaviorally active doses does not increase nicotinic cholinergic receptors in rodent brain.
    Hussmann GP; Turner JR; Lomazzo E; Venkatesh R; Cousins V; Xiao Y; Yasuda RP; Wolfe BB; Perry DC; Rezvani AH; Levin ED; Blendy JA; Kellar KJ
    J Pharmacol Exp Ther; 2012 Nov; 343(2):441-50. PubMed ID: 22899752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.